Opioids Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Opioids stocks.

Opioids Stocks Recent News

Date Stock Title
May 3 ASRT Assertio Holdings Q1 2024 Earnings Preview
May 3 AMPH Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
May 2 MJ Marijuana opposition group raising money to fight cannabis rescheduling
May 2 ALKS Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
May 2 AQST Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
May 2 AMPH Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
May 2 COLL Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
May 2 ALKS Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
May 1 MJ Schumer eyes more cannabis reforms after ‘historic’ marijuana rescheduling decision
May 1 ALKS Alkermes plc (ALKS) Q1 2024 Earnings Call Transcript
May 1 ALKS Alkermes plc 2024 Q1 - Results - Earnings Call Presentation
May 1 AMPH Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
May 1 ALKS Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
May 1 ALKS Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
May 1 ALKS Alkermes Non-GAAP EPS of $0.43 misses by $0.15, revenue of $350.4M misses by $9.87M
May 1 ALKS Alkermes plc Reports First Quarter 2024 Financial Results
Apr 30 AMPH Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
Apr 30 MJ Pot stocks surge on news of cannabis rescheduling
Apr 30 MJ DEA to reschedule marijuana as a less dangerous drug: AP
Apr 30 AMPH Why Amphastar (AMPH) Could Beat Earnings Estimates Again
Opioids

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, suppressing cough, suppressing opioid induced constipation, as well as for executions in the United States. Extremely potent opioids such as carfentanil are only approved for veterinary use. Opioids are also frequently used non-medically for their euphoric effects or to prevent withdrawal.

Side effects of opioids may include itchiness, sedation, nausea, respiratory depression, constipation, and euphoria. Tolerance and dependence will develop with continuous use, requiring increasing doses and leading to a withdrawal syndrome upon abrupt discontinuation. The euphoria attracts recreational use and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs commonly results in death from respiratory depression.Opioids act by binding to opioid receptors, which are found principally in the central and peripheral nervous system and the gastrointestinal tract. These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists, like the anti-diarrhea drug loperamide and antagonists like naloxegol for opioid-induced constipation, which do not cross the blood-brain barrier, but can displace other opioids from binding to those receptors.
Because opioids are addictive and may result in fatal overdose, most are controlled substances. In 2013, between 28 and 38 million people used opioids illicitly (0.6% to 0.8% of the global population between the ages of 15 and 65). In 2011, an estimated 4 million people in the United States used opioids recreationally or were dependent on them. As of 2015, increased rates of recreational use and addiction are attributed to over-prescription of opioid medications and inexpensive illicit heroin. Conversely, fears about over-prescribing, exaggerated side effects and addiction from opioids are similarly blamed for under-treatment of pain.

Browse All Tags